title: [Prevalence and factors related to therapeutic adherence among black African outpatients with stable coronary artery disease in a cardiology department of Dakar in Senegal].
abstract: BACKGROUND
  The management of coronary artery disease has made important progress. Adherence to therapeutic measures is a great challenge for improving the long-term prognosis. In this work, we evaluate factors related to therapeutic adherence in black African patients with stable coronary artery disease.
  
  
  METHODS
  We conducted a survey over three months (February-May 2008) in three cardiology departments in Dakar. We studied the regularity of drug intake, the adherence to the dietary advices and the appointments for consultation as well as the factors related to adherence. Good adherence was defined by a compliance rate greater or equal to 80% and a compliance rate less than 40% defined poor adherence.
  
  
  RESULTS
  We included 105 patients (61 men) with a mean age of 60.67±11.29 years. Good compliance was noted in 56.2% of cases for drug treatment, 42% for dietary advices and 65% for appointments for consultation. A history of acute coronary events (P=0.04), a good knowledge of the disease (P=0.03) and a healthcare (P=0.02) were the factors related to a good adherence to drug treatment, whereas ischemic cardiomyopathy was a factor for poor adherence (P=0.002). Knowledge of coronary disease was the only factor correlated with good adherence to lifestyle (P=0.014).
  
  
  CONCLUSIONS
  Therapeutic adherence remains unsatisfactory in Black African patients with stable coronary artery disease, hence the importance of patient education to reach a good adherence for therapeutic, because better adherence improves long-term prognosis of coronary artery disease.
authors.affiliation: Service de cardiologie, faculté de médecine, pharmacie et odontologie, université Cheikh Anta DIOP de Dakar, hôpital général de Grand Yoff de Dakar, BP 3270 Dakar, Sénégal. ambaye8@hotmail.com
authors.forename: A
authors.initials: A
authors.lastname: Mbaye
authors.forename: F L
authors.initials: FL
authors.lastname: Koukaba Ntontolo
authors.forename: A F
authors.initials: AF
authors.lastname: Diomou
authors.forename: M
authors.initials: M
authors.lastname: Bodian
authors.forename: M B
authors.initials: MB
authors.lastname: Ndiaye
authors.forename: Ad
authors.initials: A
authors.lastname: Kane
authors.forename: N V
authors.initials: NV
authors.lastname: Yaméogo
authors.forename: S
authors.initials: S
authors.lastname: Pessinaba
authors.forename: S A
authors.initials: SA
authors.lastname: Sarr
authors.forename: M
authors.initials: M
authors.lastname: Dioum
authors.forename: A
authors.initials: A
authors.lastname: Thiam
authors.forename: R
authors.initials: R
authors.lastname: Hakim
authors.forename: M
authors.initials: M
authors.lastname: Diao
authors.forename: A
authors.initials: A
authors.lastname: Kane
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000553:Ambulatory Care; D044383:Black People; D002317:Cardiovascular Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003131:Combined Modality Therapy; D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000208:ethnology; D003906:Developing Countries; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000208:ethnology; D015444:Exercise; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy / Q000208:ethnology; D006973:Hypertension / Q000188:drug therapy / Q000208:ethnology; D008297:Male; D055118:Medication Adherence / Q000208:ethnology*; D008875:Middle Aged; D056128:Obesity, Abdominal / Q000150:complications / Q000208:ethnology; D012307:Risk Factors; D057185:Sedentary Behavior; D012675:Senegal; D012907:Smoking / Q000009:adverse effects / Q000208:ethnology
chemical_list: D002317:Cardiovascular Agents